S80121
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 上海源葉生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/5/16 7:34:23
- 訪問(wèn)次數(shù) 221
聯(lián)系方式：何小姐15921386130 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
生物試劑,ELISA試劑盒,對(duì)照品,標(biāo)準(zhǔn)品,培養(yǎng)基,透析袋,病理科耗材,實(shí)驗(yàn)室耗材
- 提示：詳情請(qǐng)下載說(shuō)明書(shū)。
- 產(chǎn)品描述： WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2.
- 靶點(diǎn)： mTORC1;mTORC2;mTOR:0.19 nM (IC50);PI3Kα:1.179 μM (IC50);PI3Kδ:2.38 μM (IC50);hSMG1:1.25 μM (IC50)
- 體內(nèi)研究： A single i.v. administration of 50 mg/kg WYE-132 (WYE-125132) into tumor-bearing mice leads to suppression of P-S6K(T389) and P-AKT(S473) for at least 8 hours in PC3MM2, MDA361, HCT116, and HT29 tumors, whereas the steady-state level of P-AKT(T308) is not significantly reduced, indicating that the antitumor efficacy of WYE-132 under such dosing regimens reflects the suppression of mTOR rather than PI3K. Oral administration of WYE-132 causes dose-dependent tumor growth delay in the PI3K/mTOR- and HER2-hyperactive MDA361 tumors with significant antitumor activity at 5 mg/kg, which correlates with a suppression P-S6 and P-AKT(S473) but not P-AKT(T308). An optimal dose of 50 mg/kg WYE-132 induces a substantial regression of large MDA361 tumors. WYE-132 also causes a potent and substantial tumor growth delay in the PTEN-null U87MG glioma
- 參考文獻(xiàn)：
1. Yu K, et al. Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.Cancer Res. 2010 Jan 15;70(2):621-631.
- 溶解度： DMSO : 25 mg/mL (48.11 mM; Need ultrasonic)
- 保存條件： -20℃
- 配置溶液濃度參考：
1mg 5mg 10mg 1 mM 1.925 ml 9.623 ml 19.245 ml 5 mM 0.385 ml 1.925 ml 3.849 ml 10 mM 0.192 ml 0.962 ml 1.925 ml 50 mM 0.038 ml 0.192 ml 0.385 ml
- 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的性，僅供客戶參考交流研究之用。
相關(guān)分類
相關(guān)技術(shù)文章
- 藥用級(jí)吲哚美辛原料藥，CP藥準(zhǔn)字
- 藥用級(jí)曲安奈德原料藥，CP藥典標(biāo)
- 藥用丙酸氯倍他索軟膏原料粉末，
- 醫(yī)藥級(jí)甘氨酸原料藥準(zhǔn)字號(hào)標(biāo)準(zhǔn)供
- 藥用級(jí)氯霉素原料藥CP藥典標(biāo)準(zhǔn)詳
- 醫(yī)藥級(jí)鹽酸丁卡因原料藥供應(yīng)標(biāo)準(zhǔn)
- 藥用級(jí)冰片的藥理作用，廠家供應(yīng)
- 滅菌注射用水的執(zhí)行標(biāo)準(zhǔn)，器械用
- 醫(yī)藥級(jí)煙酰胺的使用，應(yīng)用范圍
- 咳必清鎮(zhèn)咳藥，藥用枸櫞酸噴托維
采購(gòu)中心
化工儀器網(wǎng)